Detalhe da pesquisa
1.
Interferon-ε is a tumour suppressor and restricts ovarian cancer.
Nature
; 620(7976): 1063-1070, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37587335
2.
PTEN deficiency exposes a requirement for an ARF GTPase module for integrin-dependent invasion in ovarian cancer.
EMBO J
; 42(18): e113987, 2023 09 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37577760
3.
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.
Br J Cancer
; 130(6): 941-950, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38245661
4.
Mannose impairs tumour growth and enhances chemotherapy.
Nature
; 563(7733): 719-723, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30464341
5.
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC).
Int J Gynecol Cancer
; 2024 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38760075
6.
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden.
Chemotherapy
; : 1-7, 2024 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38679017
7.
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.
Int J Gynecol Cancer
; 33(8): 1253-1259, 2023 08 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37072323
8.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(7): 919-930, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35690073
9.
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Lancet Oncol
; 23(8): e374-e384, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35901833
10.
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Lancet Oncol
; 22(2): 277-288, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33357510
11.
Characterization of patients with long-term responses to rucaparib treatment in recurrent ovarian cancer.
Gynecol Oncol
; 163(3): 490-497, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34602290
12.
Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2.
Gynecol Oncol
; 161(3): 668-675, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33752918
13.
Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management.
Int J Gynecol Cancer
; 31(2): 161-168, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33414107
14.
Metronomic oral cyclophosphamide in relapsed ovarian cancer.
Int J Gynecol Cancer
; 31(7): 1037-1044, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34016703
15.
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.
Int J Gynecol Cancer
; 31(12): 1589-1594, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34593565
16.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Lancet
; 394(10214): 2084-2095, 2019 12 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31791688
17.
Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey.
Int J Gynecol Cancer
; 30(6): 819-824, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32354792
18.
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.
Gynecol Oncol
; 154(2): 441-448, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31118141
19.
Targeting DNA repair: the genome as a potential biomarker.
J Pathol
; 244(5): 586-597, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29282716
20.
Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety.
Int J Gynecol Cancer
; 29(9): 1396-1404, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31685558